Dyslipidaemia pattern amongst diabetic patients visiting a tertiary care hospital in Eastern Odisha

Surendra Nath Behera, Shubhransu Patro


Background: With controlled blood sugar levels, the occurrence of dyslipidaemia can be reduced. Due to poor awareness and literacy being a major concern, there is an association in the incidence of dyslipidaemia and cardiovascular risk. Routine and timely observations can help health care professionals to reduce the future risk.

Methods: The current study was initiated at the Department of Medicine, KIMS, Bhubaneswar (Odisha). It included in total 669 patients, who were assigned into two groups: Group 1(Diabetic) included 364 patients and Group 2 (Non-diabetic) included 305 patients. The study patients were screened using a pretested structured questionnaire. The plan and checklist were linked by unique identification code (ID). Data was gathered in a friendly atmosphere after obtaining informed consent.

Results: In the current study, all characteristics of diabetes were correlated with each parameter and it was found that disproportionate body mass index, high waist girth was correlated with incidence of cardiovascular disease (CVD). Literacy is one of the factor found intermediate responsible for CVD. The more educated, the more advances in current lifestyle is observed whereas due to illiteracy, awareness about health issues is less and both together result in increased incidence of CVD.

Conclusions: Dyslipidaemia should be promptly diagnosed and treated aggressively to reduce the rate of morbidity and mortality in diabetic patients.


Cardiovascular risk, Cardiovascular disease, Diabetic, Morbidity, Mortality

Full Text:



Cooper GR, Myers GL, Smith SJ, Schlant RC. Blood lipid measurements: variations and practical utility. Jama. 1992;267(12):1652-60.

Grundy S, Becker D, Clark LT, Cooper RS, Denke MA, Howard J, Hunninghake DB, Illingworth DR, Luepker RV, McBride P, McKenney JM. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation-Hagertown. 2002;106(25):3143.

Selby JV, Peng T, Karter AJ, Alexander M, Sidney S, Lian J, Arnold A, Pettitt D. High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. J Americ Man care. 2004;10(2):163-70.

Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes care. 1993;16(2):434-44.

Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet. 2004;364(9438):937-52.

Tamiru S, Alemseged F. Risk Factors for Cardiovascular Diseases among Diabetic Patients In Southwest Ethiopia. Ethiopian journal of health sciences. 2010;20(2):121-8.

Powers C. Chapter. Diabetes Mellitus. In: Fauci S, Braunwald E, Kasper L, Hauser L, Longo D, Jameson L, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 17th edition. New York: McGraw Hill Medical Publishing Division; 2007. pp. 2152-68.

The DCCT Research Group. Lipid and lipoprotein levels in patients with IDDM. Diabetes Control and Complication Trial experience. Diabetes Care, 1992;15(7):886-94.

Tiwari AK. Wisdom of Ayurveda in perceiving diabetes: Enigma of therapeutic recognition. Current Science. 2005;88(7):1043-51.

Agarwal AK, Singla S, Singla S, Singla R, Lal A, Wardhan H, Yadav R. Prevalence of coronary risk factors in type 2 diabetics without manifestations of overt coronary heart disease. J Assoc Physicians India. 2009;57:135-42.

Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up study. Diabetes. 1974;23(2):105-11.

Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama. 2002;287(19):2570-81.

Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA. 2001;286(12):1468-74.

NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. The Lancet. 2016;387(10027):1513-30.

Khan M, Sakuntala P, Siddeswari R, Sudarsi B. Pattern of Dyslipidaemia in Diabetes Mellitus. Internat J Sci Res Public. 2015;5(5):1849-61.